Jiří Neumann

ORCID: 0000-0003-4857-6618
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Stroke Rehabilitation and Recovery
  • Cerebrovascular and Carotid Artery Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Neurological Disorders and Treatments
  • Peripheral Artery Disease Management
  • Cerebral Venous Sinus Thrombosis
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Arrhythmias and Treatments
  • Long-Term Effects of COVID-19
  • Pharmacogenetics and Drug Metabolism
  • COVID-19 and healthcare impacts
  • Intracranial Aneurysms: Treatment and Complications
  • Cardiac Valve Diseases and Treatments
  • Retinal and Optic Conditions
  • Computational Drug Discovery Methods
  • Hemodynamic Monitoring and Therapy
  • Education, Psychology, and Social Research
  • Coronary Interventions and Diagnostics
  • Hormonal Regulation and Hypertension
  • Climate Change and Health Impacts
  • Retinal Imaging and Analysis
  • Non-Invasive Vital Sign Monitoring
  • Trauma and Emergency Care Studies
  • Neurological Disease Mechanisms and Treatments

Krajská Zdravotní
2019-2025

Strix Chomutov (Czechia)
2025

Boston Medical Center
2021-2022

Boston University
2021-2022

Grady Memorial Hospital
2021

Universidade Federal do Rio Grande do Sul
2021

Thales (Portugal)
2020-2021

Hospital de Clínicas de Porto Alegre
2021

County Hospital
2017

Max Planck Institute for Human Cognitive and Brain Sciences
2013

Thanh N. Nguyen Muhammad M. Qureshi Piers Klein Hiroshi Yamagami Robert Mikulík and 95 more Anna Członkowska Mohamad Abdalkader Petra Šedová Anvitha Sathya Hannah Lo Malek Mansour Husitha Reddy Vanguru É. Lesaine Georgios Tsivgoulis Aaron Loochtan Jelle Demeestere Ken Uchino Violiza Inoa Nitin Goyal Andreas Charidimou James E. Siegler Shadi Yaghi Diana Aguiar de Sousa Mahmoud Mohammaden Diogo C Haussen Espen Saxhaug Kristoffersen Virginia Pujol Lereis Sergio Scollo Bruce Campbell Alice Ma James Thomas Mark Parsons Shaloo Singhal Lee‐Anne Slater Rodrigo Tomazini Martins Chris Enzinger Thomas Gattringer Aminur Rahman Thomas Bonnet Noémie Ligot Sylvie De Raedt Robin Lemmens Peter Vanacker Fenne Vandervorst Adriana Bastos Conforto Raquel C.T. Hidalgo Luciana de Oliveira Neves Rodrigo Targa Martins Daissy Liliana Mora Cuervo Letícia C. Rebello Igor Bessa Santiago Isabelle Lameirinhas da Silva Teodora Sakelarova Rosen Kalpachki Filip Alexiev Luciana Catanese Elena Adela Cora Mayank Goyal Michael D. Hill Michael Kelly Houman Khosravani Pascale Lavoie Lissa Peeling Aleksandra Pikula Rodrigo Rivera Dawei Chen Yimin Chen Xiaochuan Huo Zhongrong Miao Shuiquan Yang Marina Roje Bedeković Marina Bralić Hrvoje Budinčević Ángel Basilio Corredor-Quintero Osvaldo E. Lara-Sarabia Martin Čábal Dusan Tenora Petr Fibrich Roman Herzig Helena Hlaváčová Emanuela Hrabanovska David Hlinovský Lubomír Jurák Jana Kadlcíková Igor Karpowicz Lukáš Klečka Martin Kovář David Lauer Jiří Neumann Hana Paloušková Martin Reiser Petra Reková Vladimír Rohan Ondřej Škoda Miroslav Škorňa Lenka Sobotková Martin Šrámek Lenka Žáková Hanne Christensen Nicolas Drenck

<h3>Background and Objectives</h3> Declines in stroke admission, IV thrombolysis (IVT), mechanical thrombectomy volumes were reported during the first wave of COVID-19 pandemic. There is a paucity data on longer-term effect pandemic over course year through second We sought to measure admissions, intracranial hemorrhage (ICH), IVT, 1-year period at onset (March 1, 2020, February 28, 2021) compared with immediately preceding 2019, 29, 2020). <h3>Methods</h3> conducted longitudinal...

10.1212/wnl.0000000000201426 article EN Neurology 2022-10-18

Background and aims: Central retinal artery occlusion (CRAO) is a rare but significantly underestimated form of ischemic stroke. There still no definite recommendation for treatment. One the considered currently increasingly preferred options intravenous thrombolysis. We present results multicenter retrospective study to assess safety effectiveness thrombolytic treatment in CRAO. Methods: All patients with CRAO from six centers who received thrombolysis were included study. The intervention...

10.1161/str.56.suppl_1.wp1 article EN Stroke 2025-01-30

Introduction: Treatment of acute stroke has its clear rules and established standards. However, in the case a very early recurrence, situation is unclear, there no recommendation options are limited. We present results multicenter retrospective study using prolonged low-dose intravenous thrombolysis. Methods: The ESR_PROLONG (2020-2024) included consecutive patients who were given thrombolysis (20 mg alteplase continuously for 10 hours) during an (within hours after standard recanalization...

10.1161/str.56.suppl_1.tp8 article EN Stroke 2025-01-30

&lt;i&gt;Background:&lt;/i&gt; Public awareness campaigns are conducted to increase stroke awareness, yet evidence of their long-term effectiveness is limited. Since 2006, the Czech Stroke Society has an educational campaign throughout Republic (CR) about stroke. This report evaluates this by comparing results a nationwide survey on in 2009 with from 2005. &lt;i&gt;Methods:&lt;/i&gt; In 2009, was CR using same methodology as 2005 and employing 3-stage random sampling method (area, household,...

10.1159/000330339 article EN Cerebrovascular Diseases 2011-01-01

Knowledge of the implementation gap would facilitate use intravenous thrombolysis in stroke, which is still low many countries. The study was conducted to identify national targets for utilisation and logistics thrombolysis.Multicomponent interventions by stakeholders health care optimise prehospital hospital management with goal fast accessible every candidate. Implementation results were documented from prospectively collected cases all 45 stroke centres nationally. thrombolytic rate...

10.1177/23969873211007684 article EN European Stroke Journal 2021-04-12

This article describes policy processes that have led to the re-organisation of stroke care in Czech Republic since 2011, which has been part a broader process concentration several medical fields. Currently, is provided by 13 Comprehensive and 32 Primary Stroke Centres. The paper explains factors supported reform implementation, reviews implications, discusses future challenges. Mandatory reporting quality indicators, introduction benchmarking system, integration with pre-hospital emergency...

10.1016/j.healthpol.2021.01.011 article EN other-oa Health Policy 2021-01-30

Background and aims Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by disease-associated variants in the alpha-galactosidase A gene ( GLA ). FD known cause of stroke younger patients. There are limited data on prevalence risk unselected Methods prospective nationwide study including 35 (78%) all 45 centers consecutive patients admitted during three months. Clinical were collected RES-Q database. was diagnosed using dried blood spots stepwise manner: males—enzymatic...

10.1371/journal.pone.0260601 article EN cc-by PLoS ONE 2021-12-14

Warfarin is commonly used for the treatment and prevention of arterial venous thromboembolism but its use hindered by risk bleeding. The main reason this a narrow therapeutic index wide response variability after warfarin treatment. These shortcomings affect clinical outcomes including bleeding complications may be associated with variant polymorphisms in CYP2C9 VKORC1 genes.It was aim study to assess impact total allele count genes on related treatment.In retrospective cohort-design study,...

10.1159/000350407 article EN Cardiology 2013-01-01

Background and Purpose— Diagnostic transcranial Doppler ultrasound (TCD) is commonly used in patients with acute stroke before or during treatment intravenous thrombolysis (IVT). We aimed to assess how much TCD delays IVT initiation whether influences outcomes. Methods— analyzed data from the SITS-ISTR (Safe Implementation of Thrombolysis Stroke–International Stroke Register) collected December 2002 2011. Outcomes were door-to-needle time, symptomatic intracerebral hemorrhage, functional...

10.1161/strokeaha.118.021485 article EN Stroke 2018-05-29
Philippa C. Lavallée Hubert Charles Gregory W. Albers Louis R. Caplan Geoffrey A. Donnan and 95 more José M. Ferro Michael G. Hennerici Julien Labreuche Carlos A. Molina Peter M. Rothwell Philippe Gabríel Steg Pierre‐Jean Touboul Shinichiro Uchiyama Éric Vicaut Ka Sing Wong Pierre Amarenco Sebastián Ameriso Claudia Nora Gandolfo Guillermo Povedano Javier Sagesse H Gervas Pavón Jorge Cancino W P Toledo Yinin Huang Xiping Gong Y. Peñasco Martín Donghu Mi Tian Song Yilong Wang Yongjun Wang Fran Chandgfend Guo Contago Jiao Hongyun Heman Intao Wu Jixing Song Liquing Tai Liwen Ran Liu Shujuan Tian Wenhong Liu Tak Hong Soi Ka Sing Wong L. Barnaby Roxanna Roman Flasar Bedriska Ziktova Michael Reif Daniel Sanak Goldemund Jiří Neumann Dagmar Svakov Daniel Šaňák Michael Kral David Školoudík Daniel Václavík Martin Kuhila Pierre Amarenco Lucie Cabrejo Céline Guidoux Cristina Hobeanu Philippa C. Lavallée Elena Meseguer Henrich Audebert Daniel Menger W. Heide S. Lipp Huriye Ozalp Christine Sctzmann Christian Weimar Katharina Platzbecker Peter A. Ringleb Michel G Hennerici Martin Griebe Katrin Knoll Olaf Olaf Willmann Juergen Faiss Susan Dilan Anja Kobersteein Katarina Krimmer Sandra Tietz Peter Wienecke Gerhard F. Hamann Nico Burkhardt Martin Liebetrau Nadine Mueller Michaela Wagner Dr Strivastava Peter J. Kelly Hashomer David Tanne Milena Cavazzuti Sabrina Anticoli Danilo Toni Ken Nagata Yasushi Okada Hiroshi Yamagami Kazuo Minematsu Jojo Nakagawara Shinchiro Uchiyama Byung Chui Lee Byung Woo Yoon J. K. E. Hoe Jong Moo Park

The coexistence of underlying causes in patients with transient ischemic attack (TIA) or minor stroke as well their associated 5-year risks are not known.

10.1001/jamaneurol.2023.3344 article EN JAMA Neurology 2023-10-02

Background The benefit of intravenous thrombolysis is time dependent. It remains unclear, however, whether dramatic shortening door-to-needle (DNT) among different types hospitals nationwide does not compromise safety and still improves outcome. Methods Results Multifaceted intervention to shorten DNT was introduced at a national level, prospectively collected data from registry between 2004 2019 were analyzed. Generalized estimating equation used identify the association outcomes...

10.1161/jaha.121.023524 article EN cc-by-nc-nd Journal of the American Heart Association 2022-05-16

Objective: The objective of this study was to evaluate the feasibility and effectiveness an innovative school stroke heart attack educational programme for children. Design: Non-randomised controlled trial with intervention control group conducted in set time periods. Results were compared among periods both groups also between groups. Setting: included children from 47 schools Czech Republic. Children 37 one county ( N = 2,436) participated as target population. involved 900 pupils 10...

10.1177/0017896919849080 article EN Health Education Journal 2019-05-22

Incidence a prevalence cévní mozkové příhody (CMP) v České republice je ve srovnání s ostatními vyspělými zeměmi Evropy stále vysoká. CMP patří k nejčastějším příčinám úmrtí hlavní příčinou trvalé invalidity u dospělých. To má značný dopad na ekonomiku zdravotnictví, případě i do sociální situace nemocného. Nové postupy trendy akutní péči, které jsou uplatňovány komplexních cerebrovaskulárních centrech iktových centrech, významně zvyšují šance pacientů úspěšné vyléčení. Těžiště péče však...

10.21101/hygiena.a0983 article CS Hygiena 2013-12-01

10.1097/00000441-191412000-00030 article EN The American Journal of the Medical Sciences 1914-12-01

Data from clinical practice show that median door-to-needle time (DNT) for intravenous thrombolysis (IVT) remains around 60 minutes. However, many reports documented hospital logistics could be substantially streamlined and DNT shortened below 30 Given Czech stroke care reform, centers have recently been changing their logistical pathways with the aim to initiate IVT quicker than before.3 Several introduced one-stop management, which means all suspected acute ischemic (AIS) patients are...

10.5853/jos.2021.00878 article EN cc-by-nc Journal of Stroke 2021-09-30

Despite a significant transformation of ischaemic stroke management, it remains one the leading causes death, disability, functional impairment and cognitive deficits. With advent intravenous thrombolysis mechanical thrombectomy, is not an untreatable disease, mostly occurring in older people, any more. The most common cause cardioembolic strokes atrial fibrillation or flutter prevalent arrhythmia. aim this short communication to describe methodology Czech guidelines development....

10.1097/xeb.0000000000000190 article EN International Journal of Evidence-Based Healthcare 2019-06-01
Coming Soon ...